COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,676 Articles (22,913 medRxiv, 8,763 bioRxiv)

Most recent first Previous |  Page 434: Articles 4331-4340  | Next

Immunogenicity and safety of heterologous Omicron BA.1 and bivalent SARS-CoV-2 recombinant spike protein booster vaccines: a phase 3, randomized, clinical trial
Bennett, C., Rivers, E. J., Woo, W., Bloch, M., Cheung, K., Griffin, P., Mohan, R., Deshmukh, S., Arya, M., Cumming, O., Neville, A. M., Pardey, T. M., Plested, J. S., Cloney-Clark, S., Zhu, M., Kalkeri, R., Patel, N., Buchanan, A., Marcheschi, A., Swan, J., Smith, G., Cho, I., Glenn, G. M., Walker, R., Mallory, R.
10.1101/2023.07.05.23291954 — Posted: 2023-07-06
Intracardiac Thrombus in COVID-19 Inpatients: A Nationwide Study of Incidence, Predictors and Outcomes
Agrawal, A., Bajaj, S., Bhagat, U., Chandna, S., Arockiam, A. D., Chan, N., Haroun, E., Gupta, R., Badwan, O., Shekhar, S., Kathavarayan Ramu, S., Nayar, D., Jaber, W. A., Griffin, B. P., Wang, T. K. M.
10.1101/2023.07.05.23292278 — Posted: 2023-07-06
The receptor binding domain of SARS-CoV-2 spike protein fused with the type IIb E. coli heat-labile enterotoxin A subunit as an intranasal booster after mRNA vaccination
Hsieh, H.-C., Chen, C.-C., Chou, P.-H., Liu, W.-C., Wu, S.-C.
10.1101/2023.07.05.547781 — Posted: 2023-07-05
Risk of COVID-19 death in adults who received booster COVID-19 vaccinations: national retrospective cohort study on 14.6 million people in England
Ward, I. L., Robertson, C., Agrawal, U., Patterson, L., Bradley, D. T., Shi, T., de Lusignan, S., Hobbs, R., Sheikh, A., Nafilyan, V.
10.1101/2023.07.03.23291596 — Posted: 2023-07-05
Production and performance assessment of a SARS-CoV-2 biomimetic in a verification program for pandemic readiness
Machowski, E. E., Reyneke, A. E., Sher, D. E., Kana, B. D.
10.1101/2023.06.26.23291917 — Posted: 2023-07-04
A Radically New Theory of how the Brain Represents and Computes with Probabilities
Rinkus, R.
10.1101/162941 — Posted: 2023-07-04
Inclusion Criteria for Extracorporeal Membrane Oxygenation (ECMO) in Patients with Acute Respiratory Distress Syndrome (ARDS) Due to COVID-19: A Systematic Review
Triantafyllaki, P., Charalampopoulos, M., Sampani, C.-A., Triantafyllou, C., Papageorgiou, D.
10.1101/2023.07.01.23291847 — Posted: 2023-07-03
Projecting COVID-19 intensive care admissions in the Netherlands for policy advice: February 2020 to January 2021
Klinkenberg, D., Backer, J. A., De Keizer, N. F., Wallinga, J.
10.1101/2023.06.30.23291989 — Posted: 2023-07-03
Preventable suicides involving medicines before the covid-19 pandemic: a systematic case series of coroners reports in England and Wales (pre-print)
Anthony, G., Aronson, J. K., Brittain, R., Heneghan, C., Richards, G. C.
10.1101/2023.07.02.23292130 — Posted: 2023-07-03
Integration of human organoids single-cell transcriptomic profiles and human genetics repurposes critical cell type-specific drug targets for severe COVID-19
Ma, Y., Zhou, Y., Jiang, D., Dai, W., Li, J., Deng, C., Chen, C., Zheng, G., Zhang, Y., Qiu, F., Sun, H., Xing, S., Han, H., Qu, J., Wu, N., Yao, Y., Su, J.
10.1101/2023.07.03.23292161 — Posted: 2023-07-03

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).